1. Chemotherapy for advanced HER2-negative breast cancer: Can one algorithm fit all?. (November 2017) Authors: Miglietta, F.; Dieci, M.V.; Griguolo, G.; Guarneri, V.; Conte, P.F. Journal: Cancer treatment reviews Issue: Volume 60(2017) Page Start: 100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review. (March 2023) Authors: Miglietta, F.; Fabi, A.; Generali, D.; Dieci, M.V.; Arpino, G.; Bianchini, G.; Cinieri, S.; Conte, P.F.; Curigliano, G.; De Laurentis, M.; Del Mastro, L.; De Placido, S.; Gennari, A.; Puglisi, F.; Zambelli, A.; Perrone, F.; Guarneri, V. Journal: Cancer treatment reviews Issue: Volume 114(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes. (September 2018) Authors: Bonanno, L.; Pavan, A.; Dieci, M.V.; Di Liso, E.; Schiavon, M.; Comacchio, G.; Attili, I.; Pasello, G.; Calabrese, F.; Rea, F.; Favaretto, A.; Rugge, M.; Guarneri, V.; Fassan, M.; Conte, P.F. Journal: European journal of cancer Issue: Volume 101(2018) Page Start: 191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗